Related Experiment Video
Updated: Dec 4, 2025

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
Published on: January 9, 2020
Apigenin Inhibits Proliferation, Migration, and Invasion of Human Tongue Carcinoma Tca8113 Cells Through Regulating
Yun-Ze Xuan1, Li-Zhi Xu2, Cheng-Ri Jin1
1Department of Dentistry, Affiliated Hospital of Yanbian University, Yanji, Jilin 133000, China.
Objective:
This study aimed to examine the effects of apigenin (API) on the proliferation, migration, and invasion of human tongue squamous cell carcinoma Tca8113 cells and explore its probable mechanisms.
Methods:
After treating Tca8113 cells with API, the cell proliferation, migration, and invasive capacities were identified by tetrazolium salt colorimetry (MTT) assay, cell scratch test, and Transwell chamber test. Cellular immunofluorescence staining was used to localize mitogen-activated protein kinase 1 (MAPK1) and extracellular regulated protein kinase (ERK) 1/2 proteins. Western blot was used to detect the variations of the related protein expression levels.
Results:
1)Through the MTT assay, API significantly inhibited cell proliferation (P<0.01). 2) In the cell scratch test, the distance of lateral migration after the API treatment was significantly shorter compared to the control group (P<0.01). 3) The invasion rate in the lower chamber of the Transwell chamber was lower in the API group (P<0.01). 4) Cellular immunofluorescence staining presented that the total-MEKK1 was localized in the cytoplasm, p-MEKK1 was localized in the nuclear membrane and cytoplasm, and p-ERK1/2 was localized in the cytoplasm and nucleus. ⑤ After API was applied to cells, the expressions of p-MEKK1 and p-ERK1/2 proteins significantly reduced (P<0.01).
Conclusion:
Apigenin (API) significantly inhibits the proliferation, migration, and invasion of Tca8113 cells and its mechanism may be associated with the MAPK signaling pathway.
Insights
Apigenin (API) effectively inhibits tongue cancer cell growth, migration, and invasion. Its mechanism involves downregulating the MAPK signaling pathway, offering potential therapeutic insights.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Human tongue squamous cell carcinoma (Tca8113) exhibits aggressive proliferation, migration, and invasion.
- Understanding the molecular mechanisms underlying cancer progression is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the effects of apigenin (API) on Tca8113 cell behavior.
- To elucidate the potential mechanisms, including the involvement of the MAPK signaling pathway.
Main Methods:
- Cell proliferation was assessed using MTT assay.
- Migration and invasion were evaluated by cell scratch and Transwell assays.
- Protein expression and localization (MAPK1, ERK1/2) were analyzed via immunofluorescence and Western blot.
Main Results:
- Apigenin significantly inhibited Tca8113 cell proliferation (P<0.01).
- API treatment markedly reduced cell migration and invasion capabilities (P<0.01).
- Apigenin decreased the expression of phosphorylated MEKK1 and ERK1/2 proteins (P<0.01).
Conclusions:
- Apigenin demonstrates potent anti-cancer effects against tongue squamous cell carcinoma Tca8113 cells.
- The observed effects are potentially mediated through the modulation of the MAPK signaling pathway.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation

